J. Perinat. Med, 2016 Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP) Christian Breymann*, Nils Milman, Anna Mezzacasa, Roubert Bernard and Joachim Dudenhausen, on behalf of the FER-ASAP investigators *Corresponding author: Christian Breymann, MD, Clinic of Obstetrics, Obstetric Research and Feto-Maternal Haematology Unit, University HospitalZürich, Frauenklinikstrasse 10, CH-8091 Zürich, Switzerland Nils Milman: Departments of Clinical Biochemistry ...
Read More

Volume 49, December 2009, TRANSFUSION 2719 Large dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. David B. VanWyck, Antoinette Mangione, John Morrison, Phillip Earl Hadley, Judi A. Jehle, and Lawrence Tim Goodnough for the Ferric Carboxymaltose Study Group From DaVita, Inc., Tucson, Arizona; American Regent/Luitpold Pharmaceuticals, Norristown, Pennsylvania; the University of Mississippi Medical Center, Jackson, Mississippi; the Medical Network for Education ...
Read More

Am J Obstet Gynecol, 2008 Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial Melvin H. Seid, MD, FACOG, CPI; Richard J. Derman, MD, FACOG; Jeffrey B. Baker, MD, FACOG; Warren Banach, MD, FACOG; Cynthia Goldberg, MD, FACOG; Ralph Rogers, MD, FACOG From Lyndhurst Gynecologic Associates, Winston-Salem, NC (Dr Seid); University of Missouri–Kansas City, Kansas City, MO (Dr Derman); Rosemark WomenCare Specialists, Idaho ...
Read More